Pfizer (PFE) Tops Q4 EPS by 1c
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $27.79 -2.32%
Revenue Growth %: -4.4%
Financial Fact:
Discontinued operations--net of tax (in dollars per share): 0
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: -4.4%
Financial Fact:
Discontinued operations--net of tax (in dollars per share): 0
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q4 EPS of $0.53, $0.01 better than the analyst estimate of $0.52. Revenue for the quarter came in at $14.05 billion versus the consensus estimate of $13.57 billion.
Guidance:
The Company sees FY16 EPS of $2.20 - $2.30 and revenue of $49 - $51 billion. The Street is looking for EPS of $2.36 and revenue of $52.5 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- UBS upgrades Lockheed Martin to Buy, sees 26% upside on missile growth
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
